BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 26899900)

  • 1. A retrospective cohort study in patients with tractional diseases of the vitreomacular interface (ReCoVit).
    Stalmans P
    Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):617-28. PubMed ID: 26899900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANATOMICAL AND FUNCTIONAL OUTCOMES OF SYMPTOMATIC IDIOPATHIC VITREOMACULAR TRACTION: A Natural History Study From the Pan American Collaborative Retina Study Group.
    Wu L; Zas M; Berrocal MH; Arevalo JF; Figueroa M; Rodriguez F; Serrano M; Graue F; Alezzandrini A; Gallego-Pinazo R; Roca JA; Iglicki M; Dalma-Weishauz J; Kozak I; Collado A; Badal J; Maia M; Salcedo-Villanueva G; Quiroz-Mercado H; Fromow-Guerra J; Lozano-Rechy D; Avila M; Chhablani J
    Retina; 2016 Oct; 36(10):1913-8. PubMed ID: 26966868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography.
    Theodossiadis GP; Grigoropoulos VG; Theodoropoulou S; Datseris I; Theodossiadis PG
    Am J Ophthalmol; 2014 Apr; 157(4):842-851.e1. PubMed ID: 24445034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Ciulla TA; Ying GS; Maguire MG; Martin DF; Jaffe GJ; Grunwald JE; Daniel E; Toth CA;
    Ophthalmology; 2015 Jun; 122(6):1203-11. PubMed ID: 25824327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Course of Vitreomacular Traction Managed Initially by Observation.
    Tzu JH; John VJ; Flynn HW; Smiddy WE; Jackson JR; Isernhagen BA; Carver A; Leonard R; Tabandeh H; Boyer DS; Berrocal MH; Suzuki M; Freund KB; Gross JG
    Ophthalmic Surg Lasers Imaging Retina; 2015 May; 46(5):571-6. PubMed ID: 26057761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural course of vitreomacular traction syndrome observed by spectral-domain optical coherence tomography.
    Zhang Z; Dong F; Zhao C; Dai R; Yu W; Zheng L; He F; Yang Z
    Can J Ophthalmol; 2015 Apr; 50(2):172-9. PubMed ID: 25863860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. THE EFFECT OF ELECTIVE CATARACT EXTRACTION BY PHACOEMULSIFICATION IN EYES WITH VITREOMACULAR TRACTION SYNDROME.
    Mantopoulos D; Prenner JL; Patel VK; Roth DB; Shah SP; Tsavaris O; Fine HF; Wheatley HM
    Retina; 2021 Jan; 41(1):75-81. PubMed ID: 32106158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography.
    Odrobina D; Michalewska Z; Michalewski J; Dzięgielewski K; Nawrocki J
    Retina; 2011 Feb; 31(2):324-31. PubMed ID: 21416651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel spectral-domain optical coherence tomography model to estimate changes in vitreomacular traction syndrome.
    Codenotti M; Iuliano L; Fogliato G; Querques G; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1729-35. PubMed ID: 24764038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer retina reflectivity changes on sd-oct after intravitreal ocriplasmin for vitreomacular traction and macular hole.
    Quezada-Ruiz C; Pieramici DJ; Nasir M; Rabena M; Steinle N; Castellarin AA; Dhoot D; Couvillion S; See RF; Avery RL
    Retina; 2015 Jun; 35(6):1144-50. PubMed ID: 25961122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OCT proves that vitreomacular adhesion is significantly more likely to develop vision-threatening retinal complications than vitreomacular separation.
    Liao DY; Liu JH; Zheng YP; Shiu HW; Wang JM; Chao HM
    BMC Ophthalmol; 2020 Apr; 20(1):163. PubMed ID: 32321473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocriplasmin Treatment Leads to Symptomatic Vitreomacular Adhesion/Vitreomacular Traction Resolution in the Real-World Setting: The Phase IV ORBIT Study.
    Khanani AM; Duker JS; Heier JS; Kaiser PK; Joondeph BC; Kozma P; Rosberger DF; MacCumber M; Boyer DS; Pieramici DJ
    Ophthalmol Retina; 2019 Jan; 3(1):32-41. PubMed ID: 30935657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate and timing of spontaneous resolution in a vitreomacular traction group: should the role of watchful waiting be re-evaluated as an alternative to ocriplasmin therapy?
    Dimopoulos S; Bartz-Schmidt KU; Gelisken F; Januschowski K; Ziemssen F
    Br J Ophthalmol; 2015 Mar; 99(3):350-3. PubMed ID: 25342274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Results in Ocriplasmin Candidates With Symptomatic Vitreomacular Traction Syndrome.
    Vasquez DH; Altamirano JC; Casaus A; Del Valle RA; Gonzalez R; Gonzalez-De La Rosa A; Navarro-Partida J; Vasquez MA; Santos A
    Curr Eye Res; 2018 Feb; 43(2):208-212. PubMed ID: 29111823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PNEUMATIC VITREOLYSIS FOR RELIEF OF VITREOMACULAR TRACTION.
    Chan CK; Crosson JN; Mein CE; Daher N
    Retina; 2017 Oct; 37(10):1820-1831. PubMed ID: 28099316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diseases of the vitreo-macular interface].
    Koerner F; Garweg J
    Klin Monbl Augenheilkd; 1999 May; 214(5):305-10. PubMed ID: 10420374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study.
    Chatziralli I; Theodossiadis G; Parikakis E; Datseris I; Theodossiadis P
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):223-33. PubMed ID: 25940555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PNEUMATIC VITREOLYSIS VERSUS PARS PLANA VITRECTOMY IN FOCAL SYMPTOMATIC VITREOMACULAR TRACTION SYNDROME: A Randomized Trial.
    Kumar V; Sonkar R; Verma S; Azad SV; Chawla R; Venkatesh P; Vohra R; Kumar A
    Retina; 2022 Jul; 42(7):1277-1283. PubMed ID: 35723920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion/vitreomacular traction, including when associated with macular hole.
    Gandorfer A; Benz MS; Haller JA; Stalmans P; Pakola SJ; Girach A; Kampik A; Toth CA; Jaffe GJ;
    Retina; 2015 Jun; 35(6):1151-7. PubMed ID: 25741816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study.
    Greven MA; Garg S; Chiu B; Shah SP; Wolfe J; Fine HF; Roth DB; Robinson J; Mong J; Hsu J; Regillo C; Ho A; Haller JA
    Br J Ophthalmol; 2016 Sep; 100(9):1211-5. PubMed ID: 26659344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.